Integrative Potential and Clinical Insight From a functional medicine perspective, GLP-1, GLP-2, and VIP peptides could become adjunctive supports in MCAS and related conditions such as IBS, POTS, EhlersDanlos syndrome, chronic fatigue, and long COVID, where mast-celldriven neuroinflammation plays a central role
-Chris Carberg, Founder, AddictionHelp.com Get Treatment Help If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp
However, only Wegovy is a weight-loss drug
Comparison of Multi-Receptor Agonists
While most were developed to treat type 2 diabetes, many have subsequently been found to offer health benefits for people with obesity and cardiovascular disease, and to reduce the risk of kidney failure in people with and without diabetes
Heres what each one does to potentially help with weight loss, what the research shows, and whether it makes a difference